1399258-99-1

Upstream product

• 432529-50-5 4-(4-fluorobenzyloxy)benzaldehyde oxime 
• 56442-17-2 4-((4-fluorobenzyl)oxy)benzaldehyde 

Downstream Products

• 1399259-07-4 (4aS,4bR,5S,6aS,6bR,9aS,10aS,10bS,12S)-4b,12-difluoro-8-[4-(4-fluoro-benzyloxy)-benzyl]-5-hydroxy-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,8,9,9a,10,10a,10b,11,12-tetradecahydro-7-oxa-8-aza-pentaleno[2,1-a]phenanthrene-6b-carboxylic acid 
• 1399259-09-6 (4aS,4bR,5S,6aS,6bR,9aS,10aS,10bS,12S)-8-((4-fluoro-benzyloxy)-benzyl)-4b,12-difluoro-5-hydroxy-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,8,9,9a,10,10a,10b,11,12-tetradecahydro-7-oxa-8-aza-pentaleno[2,1-a]phenanthrene-6b-carbothioic acid S-fluoromethyl ester 

Relevant academic research and scientific papers

ISOXAZOLIDINE DERIVATIVES

Anti-inflammatory and antiallergic compounds of the glucocorticosteroid series according to formula (I) defined herein are useful for treating diseases of the respiratory tract characterized by airway obstruction.

ISOXAZOLIDINE DERIVATIVES

The present invention relates to novel anti-inflammatory and antiallergic compounds of the glucocorticosteroid series, methods of preparing such compounds, pharmaceutical compositions comprisingthem, combinations and therapeutic uses thereof. More particularly, the invention relates to glucocorticosteroids that are derivatives of isoxazolidine.